- PICC Group’s preliminary full-year net income is estimated to be between 39.85 billion yuan and 44.41 billion yuan.
- The company has shown a commitment to high-quality development.
- PICC Group has continuously optimized its business structure.
- Analyst ratings include 13 buy recommendations, 5 holds, and no sell recommendations.
“`
A look at People’s Insurance (PICC) Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
The People’s Insurance Company (Group) of China Limited (PICC) seems to have a bright long-term outlook based on the Smartkarma Smart Scores. With a top score in both value and dividend factors, PICC indicates strong fundamentals and a commitment to rewarding its investors. Additionally, scoring high in momentum suggests that the company is on a positive trajectory in terms of market performance. While growth and resilience scores slightly lower, overall, the outlook for People’s Insurance (PICC) appears promising for investors looking for stable returns.
Being a key player in the insurance sector, The People’s Insurance Company of China Limited offers a range of property and casualty insurance products, catering to various customer needs in China. Furthermore, the company provides asset management services, showcasing its diversification and commitment to serving a broad base of clients throughout the country. With top scores in value, dividend, and momentum, PICC’s future prospects look favorable, positioning it as a promising investment opportunity for those seeking a reliable and rewarding option in the insurance industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
